Pre-exposure of human squamous carcinoma cells to low-doses of gamma-rays leads to an increased resistance to subsequent low-dose cisplatin treatment

By Caney C.   Bulmer J. T.   Singh G.   Lukka H.   Rainbow A. J.  

International Journal of Radiation Biology, Vol. 75, Iss. 8, 1999-08 ,pp. : 963-972

Informa Healthcare

Access to resources Recommend Favorite

Sequence-dependent synergism between the new generation platinum agent ZD0473 and paclitaxel in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

By Rogers P.   Boxall F.E.   Allott C.P.   Stephens T.C.   Kelland L.R.  

European Journal of Cancer, Vol. 38, Iss. 12, 2002-08 ,pp. : 1653-1660

Elsevier

Access to resources Recommend Favorite

Effects of a novel trinuclear platinum complex in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines: interference with cell cycle progression and induction of apoptosis

By Orlandi L.   Colella G.   Bearzatto A.   Abolafio G.   Manzotti C.   Daidone M.G.   Zaffaroni N.  

European Journal of Cancer, Vol. 37, Iss. 5, 2001-03 ,pp. : 649-659

Elsevier

Access to resources Recommend Favorite

Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines

By Kelland L.R.   Kimbell R.   Hardcastle A.   Aherne G.W.   Jackman A.L.  

European Journal of Cancer, Vol. 31, Iss. 6, 1995-06 ,pp. : 981-986

Elsevier

Access to resources Recommend Favorite

The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway

By                      

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 619-624

Spandidos Publications

Access to resources Recommend Favorite